Literature DB >> 1616660

Clinical implications of recovery of Mycobacterium avium complex from the stool or respiratory tract of HIV-infected individuals.

C R Horsburgh, B G Metchock, J E McGowan, S E Thompson.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1616660

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  PCR comparison of Mycobacterium avium isolates obtained from patients and foods.

Authors:  S Yoder; C Argueta; A Holtzman; T Aronson; O G Berlin; P Tomasek; N Glover; S Froman; G Stelma
Journal:  Appl Environ Microbiol       Date:  1999-06       Impact factor: 4.792

Review 2.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

3.  Comparison of four decontamination methods for recovery of Mycobacterium avium complex from stools.

Authors:  D M Yajko; P S Nassos; C A Sanders; P C Gonzalez; A L Reingold; C R Horsburgh; P C Hopewell; D P Chin; W K Hadley
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

Review 4.  [Disseminated infection with Mycobacterium avium complex (MAC) in HIV infection].

Authors:  G Fätkenheuer; B Salzberger; V Diehl
Journal:  Med Klin (Munich)       Date:  1998-06-15

5.  TGF-β-mediated sustained ERK1/2 activity promotes the inhibition of intracellular growth of Mycobacterium avium in epithelioid cells surrogates.

Authors:  Carolina L'Abbate; Ivone Cipriano; Elizabeth Cristina Pérez-Hurtado; Sylvia Cardoso Leão; Célia Regina Whitaker Carneiro; Joel Machado
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

6.  Evaluation of amplified rDNA restriction analysis (ARDRA) for the identification of cultured mycobacteria in a diagnostic laboratory.

Authors:  Thierry De Baere; Ricardo de Mendonça; Geert Claeys; Gerda Verschraegen; Wouter Mijs; Rita Verhelst; Sylvianne Rottiers; Leen Van Simaey; Catharine De Ganck; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2002-03-01       Impact factor: 3.605
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.